5/21/2013 1:00:00 AM
KineMed Inc. announces an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to study how a monoclonal antibody affects the dynamics of the cellular prion protein (PrPc).
3/27/2013 12:00:00 AM
KineMed renews diabetes collaboration with Pfizer Inc
3/13/2013 12:00:00 AM
KineMed presents Applications of Kinetic Biomarkers to Diagnose and Treat Neurological Disorders at the 2nd Neurological Biomarkers Conference
|
Dr. Marc Hellerstein, Chair of KineMed´s Scientific Advisory Board talks about the power of Proteome Dynamics at the Personalized Medicine World Conference
|